Albutoin
- Level
- Commodity
- Parent
- 51141500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51141545This classification denotes an anticonvulsant agent with the molecular formula C10H16N2OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 475NGR2DC1, chemically known as 4-imidazolidinone, 5-(2-methylpropyl)-3-(2-propenyl)-2-thioxo- but generally known as albutoin, which bears US NIH Compound Identifier 3032361. European Medicines Agency schedules Albutoin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05298MIG. The term ALBUTOIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). ALBUTOIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule albutoin under HS 29332990 and SITC 51573. As of Q4 2014, ALBUTOIN remains the US FDA Preferred Term for this commodity. Albutoin bears US NLM identifiers UMLS ID C0051108 and NCI Concept Code C90706. SMILES: CC(C)CC1C(=O)N(C(=S)N1)CC=C.
Same parent
Under 51141500 · 80Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.